ALMKT:EPA
Mauna Kea Technologies SA
0,092 €
0,00%
(0,00) 1D
13 nën, 5:35:01 m.d., GMT+1 · EUR
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për ALMKT...
Hap
0,09 €
I lartë
0,10 €
I ulët
0,09 €
Kapitalizimi i tregut
18,14 mln
Vëllimi mesatar
541,14 mijë
Vëllimi
75,16 mijë
Raporti çmim/fitim
0,79
Maksimumi 52-javor
0,23 €
Minimumi 52-javor
0,07 €
Fitimet për aksion
0,12 €
Aksionet në qarkullim
195,26 mln
Numri i punonjësve
56
Hap
0,09 €
I lartë
0,10 €
I ulët
0,09 €
Kapitalizimi i tregut
18,14 mln
Vëllimi mesatar
541,14 mijë
Vëllimi
75,16 mijë
Raporti çmim/fitim
0,79
Maksimumi 52-javor
0,23 €
Minimumi 52-javor
0,07 €
Fitimet për aksion
0,12 €
Aksionet në qarkullim
195,26 mln
Numri i punonjësve
56
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
TradingView
·
5 orë më parë
EXCLUSIVE: S&P 500’s Sell-Off Tested Buffered ETFs: Expert Explains Why a 10% Buffer May Not Protect You as Expected
24/7 Wall St.
·
1 orë më parë
He Thinks His $200,000 S&P 500 401(k) Spreads His AI Risk. Two Alphabet Share Classes Put $10,380 in One Company. A 20% Drop Could Cost Him $2,076
Bloomberg.com
·
10 orë më parë
SpaceX’s S&P 500 Bid Gets New Life as Musk Pitches Tesla Merger
Traders Union
·
5 orë më parë
Michael Kantro: Institutional investors focus on stock picking as S&P 500 targets have lost relevance
Profili
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
Rreth Mauna Kea Technologies SA
Drejtori ekzekutivSacha Loiseau
Punonjësit56
Themeluar më2000
Selia-
SektoriHealth Care
IndustriaMedical device
Uebsajtimaunakeatech.com